Saroglitazar magnesiumProduct ingredient for Saroglitazar
- Name
- Saroglitazar magnesium
- Drug Entry
- Saroglitazar
Saroglitazar has been investigated for the treatment of Fatty Liver.
- Accession Number
- DBSALT003454
- Structure
Structure for Saroglitazar magnesium (DBSALT003454)
- Synonyms
- (2S)-2-ETHOXY-3-(4-(2-(2-METHYL-5-(4-(METHYLSULFANYL)PHENYL)-1H-PYRROL-1-YL(ETHOXY)PHENYL)PROPANOIC ACID, MAGNESIUM SALT (2:1) / LIPAGLYN / MAGNESIUM, BIS((.ALPHA.S)-.ALPHA.-(ETHOXY-.KAPPA.O)-4-(2-(2-METHYL-5-(4-(METHYLTHIO)PHENYL)-1H-PYRROL-1-YL)ETHOXY)BENZENEPROPANOATO-.KAPPA.O)-, (T-4)-
- UNII
- K8V5DLS63R
- CAS Number
- 1639792-20-3
- Weight
- Average: 901.43
Monoisotopic: 900.33285082 - Chemical Formula
- C50H56MgN2O8S2
- InChI Key
- UJYFZCVPOSZDMK-YPPDDXJESA-L
- InChI
- InChI=1S/2C25H29NO4S.Mg/c2*1-4-29-24(25(27)28)17-19-6-10-21(11-7-19)30-16-15-26-18(2)5-14-23(26)20-8-12-22(31-3)13-9-20;/h2*5-14,24H,4,15-17H2,1-3H3,(H,27,28);/q;;+2/p-2/t2*24-;/m00./s1
- IUPAC Name
- magnesium(2+) bis((2S)-2-ethoxy-3-[4-(2-{2-methyl-5-[4-(methylsulfanyl)phenyl]-1H-pyrrol-1-yl}ethoxy)phenyl]propanoate)
- SMILES
- [Mg++].CCO[C@@H](CC1=CC=C(OCCN2C(C)=CC=C2C2=CC=C(SC)C=C2)C=C1)C([O-])=O.CCO[C@@H](CC1=CC=C(OCCN2C(C)=CC=C2C2=CC=C(SC)C=C2)C=C1)C([O-])=O
- External Links
- ChemSpider
- 58828193
- Predicted Properties
Property Value Source logP 5.53 Chemaxon pKa (Strongest Acidic) 3.73 Chemaxon pKa (Strongest Basic) -4.1 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 4 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 63.52 Å2 Chemaxon Rotatable Bond Count 22 Chemaxon Refractivity 136.93 m3·mol-1 Chemaxon Polarizability 48.31 Å3 Chemaxon Number of Rings 6 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon